Chonluten
also known as bronchial bioregulator, respiratory peptide complex
Khavinson-school bioregulatory peptide complex targeting bronchial mucosa and respiratory epithelium. Preclinical data demonstrate modulation of proliferative activity and inflammatory pathways in monocyte/macrophage cell lines. Part of the Russian bioregulator tradition with tissue-specific organ peptide architecture. Limited Western research indexing; mechanistic evidence from in vitro models.
At a glance
Oral · Sublingual · Per Protocol
Primary target — Bronchial epithelial cells and respiratory mucosa tissue complexes.
Pathway — Bioregulatory peptide interaction → modulation of proliferative and inflammatory pathways in monocyte/macrophage populations [avolio-2022].
Downstream effect — Regulation of proliferative activity and inflammatory mediator production in respiratory-associated immune cells [avolio-2022].
Origin — Khavinson bioregulator peptide complex derived from bronchial mucosa tissue extract methodology.
| Parameter | Value |
|---|---|
| Typical protocol dose | 10–20 mg / dayRussian bioregulator tradition dosing; not standardized in Western literature. |
| Frequency | Once or twice daily |
| Route | Oral (capsule) or sublingualSublingual claimed for enhanced bioavailability; not validated. |
| Evidence basis | In vitro mechanistic |
| Duration | 10–30 days per cycleTraditional Khavinson protocol; cyclic administration common. |
| Clinical validation | None (PubMed indexed) |
Reconstitution
A pure mass-to-volume utility. Enter what you have in the vial; the atlas computes the volume per dose. No prescription information.
- — Known hypersensitivity to peptide components
- — Pregnancy and lactation (insufficient data)
- — Active malignancy (theoretical bioregulator concern)
- 01Preparation
Typically supplied as capsules or sublingual tablets. No reconstitution required. Store in cool, dry place away from light.
- 02Oral route
Swallow capsule with water, 20–30 minutes before meals or as directed. Traditional Khavinson protocol emphasizes empty stomach for absorption.
- 03Sublingual route
Place tablet under tongue, allow dissolution for 1–2 minutes. Avoid swallowing immediately. Claimed to bypass first-pass metabolism.
- 04Timing
Morning dose preferred; may split into twice-daily if higher dose used. Consistency emphasized in bioregulator protocols.
- 05Cycle protocol
10–30 day cycles common in Russian tradition. Rest period of 1–3 months between cycles often recommended, though no published evidence for this approach.
Sources
of 38 rendered claims carry a resolvable citation.
- [avolio-2022]Avolio 2022 — Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.
journal, 2022